Attenuation of Atherosclerosis With PAR4 Deficiency: A Potential Role of Hematopoietically Expressed PAR4 in Atherosclerosis—Brief Report
Caris Wadding-Lee(University of Cincinnati), A. Phillip Owens(Maine Farmland Trust), Joel Thompson(Children's Mercy Hospital), Nigel Mackman(University of North Carolina at Chapel Hill), Alan Daugherty(The Graduate Center, CUNY), Benjamin E. Tourdot(Cincinnati Children's Hospital Medical Center), Tyler W. Benson(Augusta University), Anthony Spuzzillo(University of Cincinnati), Megan Jay(University of Cincinnati Medical Center), Deborah A. Howatt(University of Kentucky)
Cited by 3
Related Papers
Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions.
|Journal of Clinical Investigation|1994|1.3k
Role of tissue factor in embryonic blood vessel development
|Nature|1996|678
Venous thrombosis
|Nature Reviews Disease Primers|2015|378
Elevated Cyclic AMP Inhibits NF-κB-mediated Transcription in Human Monocytic Cells and Endothelial Cells
|Journal of Biological Chemistry|1996|338